L
Lytix Biopharma AS
OSE:LYTIX
Lytix Biopharma AS
OSE:LYTIX
Price:
5.3
NOK
-0.38%
Market Closed
Market Cap:
361.8m
NOK
P/OCF
Price to OCF
Price to OCF
-4.4
Current
-5.5
Median
19.3
Industry
Higher
than median
Lower
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=-4.4
Market Cap
/
361.8m NOK
Operating Cash Flow
-81.5m NOK
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
